paroxetine mesylate · Legacy · NDA 204516
Brisdelle
Earliest generic entry, as listed
6 Apr 2029
Blocked by patent: US 8658663.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 8658663 | drug substance, drug product, use U-904 · sets the listed date | 6 Apr 2029 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 204516 · 001 · RLD | capsule, oral | EQ 7.5MG BASE | 6 Apr 2029 |
Expired or delisted (2)
- US 8946251 · substance, product, use U-904 · 4 Aug 2026
- US 9393237 · use U-904 · 4 Aug 2026